RxDoctor Payments Data

Natalie Cooper, MD

Physical Medicine & Rehabilitation · Spokane, WANPI 1104138247

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $300 and has fallen 51.4% since, to $145 in 2025.

$1,218in general payments, 2019–2025

Across 54 payments — averaging $22.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$254
  • Organogenesis Inc.$214
  • AbbVie$154
  • Solventum Corporation$119
  • Hydrofera LLC$81
  • Amgen$74
  • plus $323 from 8 others

What the payments were for

  • Food & beverage$1,218100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,218 in reported general payments places this provider in the 80th percentile of 260 physical medicine & rehabilitation providers in Washington.

See all physical medicine & rehabilitation providers in Washington

Medicare billing

Part B allowed, 2024
$38,526
Medicare patients
86
Services billed
559

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate20$638
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$184
Ciprofloxacin Hcl11$151

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →